The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $57.48

Today's change-0.86 -1.47%
Updated March 31 4:02 PM EDT. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $57.48

Today's change-0.86 -1.47%
Updated March 31 4:02 PM EDT. Delayed by at least 15 minutes.

Merck & Co Inc crosses below 20-day moving average

Merck & Co Inc closed lower Tuesday, dropping (U.S.)$0.86 or 1.47% to (U.S.)$57.48 and crossing below its 20-day moving average. Shares have lost 1.96% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 9.19% during the last year.

Key company metrics

  • Open(U.S.) $58.19
  • Previous close(U.S.) $58.34
  • High(U.S.) $58.31
  • Low(U.S.) $57.48
  • Bid / Ask-- / --
  • YTD % change+1.22%
  • Volume10,458,696
  • Average volume (10-day)13,096,490
  • Average volume (1-month)12,249,865
  • Average volume (3-month)11,420,730
  • 52-week range(U.S.) $52.49 to (U.S.) $63.62
  • Beta0.33
  • Trailing P/E14.03×
  • P/E 1 year forward17.24×
  • Forward PEG3.60×
  • Indicated annual dividend(U.S.) $1.80
  • Dividend yield3.13%
  • Trailing EPS(U.S.) $4.10
Updated March 31 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+28.25%

Based on its net profit margin of 28.25%, Merck & Co Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue10,48210,55710,93410,264
Total other revenue--------
Total revenue10,48210,55710,93410,264
Gross profit6,8386,4216,2126,361
Total cost of revenue3,6444,1364,7223,903
Total operating expense9,3069,2339,6938,336
Selling / general / administrative2,7872,7972,8972,734
Research & development2,0811,4841,6211,574
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)794816453125
Other operating expenses, total--------
Operating income1,1761,3241,2411,928
Interest income (expense), net non-operating-165-191-188--
Gain (loss) on sale of assets--------
Other--------
Income before tax11,8111,4901,8912,091
Income after tax7,3278422,0331,731
Income tax, total4,484648-142360
Net income7,3168952,0041,705
Total adjustments to net income--------
Net income before extra. items7,3168952,0041,705
Minority interest-1153-29-26
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items7,3168952,0041,705
Inc. avail. to common incl. extra. items7,3168952,0041,705
Diluted net income7,3168952,0041,705
Dilution adjustment--000
Diluted weighted average shares2,8862,9112,9492,971
Diluted EPS excluding extraordinary itemsvalue per share2.540.310.680.57
Dividends per sharevalue per share0.440.440.440.44
Diluted normalized EPSvalue per share4.410.470.780.61